Literature DB >> 2393389

K252a is a potent and selective inhibitor of phosphorylase kinase.

L H Elliott1, S E Wilkinson, A D Sedgwick, C H Hill, G Lawton, P D Davis, J S Nixon.   

Abstract

The inhibition of phosphorylase kinase by a number of protein kinase inhibitors was examined. Both K252a and staurosporine are potent inhibitors of phosphorylase kinase with IC50 values of 1.7 nM and 0.5 nM respectively. K252a shows a 300-fold selectivity for this enzyme over protein kinase C whereas staurosporine shows only a 20-fold selectivity for phosphorylase kinase. In contrast, the Roche bis-indolyl maleimides inhibit phosphorylase kinase with IC50 values of approximately 1 microM and are highly selective for protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393389     DOI: 10.1016/0006-291x(90)91369-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.

Authors:  A C Newby; K Lim; M A Evans; N P Brindle; R F Booth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

2.  Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1.

Authors:  R M Böhmer; E Scharf; R K Assoian
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

3.  Regulation of neuronal excitability by release of proteins from glial cells.

Authors:  Birte A Igelhorst; Vanessa Niederkinkhaus; Claudia Karus; Maren D Lange; Irmgard D Dietzel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

4.  Inhibition of nicotinic responses of bovine adrenal chromaffin cells by the protein kinase C inhibitor, Ro 31-8220.

Authors:  P D Marley; K A Thomson
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

5.  Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.

Authors:  S E Wilkinson; P J Parker; J S Nixon
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

6.  Possible roles of protein kinases in neutrophil chemotactic factor production by leucocytes in allergic inflammation in rats.

Authors:  J Tanabe; M Watanabe; S Kondoh; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 7.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

8.  Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.

Authors:  Wan Seok Yang; Katherine J Kim; Michael M Gaschler; Milesh Patel; Mikhail S Shchepinov; Brent R Stockwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-09       Impact factor: 11.205

9.  Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils.

Authors:  U Amon; E von Stebut; H H Wolff
Journal:  Agents Actions       Date:  1993-05

10.  Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun.

Authors:  E Razin; Z Szallasi; M G Kazanietz; P M Blumberg; J Rivera
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.